Testing Modalities for Inborn Errors of Metabolism — What a Clinician Needs to Know?
- 1 September 2019
- journal article
- research article
- Published by Springer Nature in Indian Pediatrics
- Vol. 56 (9) , 757-766
Abstract
The present century is being hailed as the century for genetic therapies, and inborn errors of metabolism is leading the way. As we gear ourselves for treating children with genetic and metabolic disorders, the key is to recognize them early and accurately for best outcomes. In these changing times with advent of technology, clinicians are now more aware, exposed and well equipped with the armamentarium of diagnostic modalities. However, it is difficult to choose between the tests without a baseline knowledge about testing for genetic and metabolic disorders. The key question for a clinician when dealing with a suspected metabolic disorder case is ‘what test to order’ and ‘how to proceed.’ The current article provides a rational view on the various laboratory testing modalities available for diagnosis of inborn errors of metabolism. The article provides details of the basic and advanced metabolic tests that can be ordered in appropriate settings.Keywords
This publication has 19 references indexed in Scilit:
- Measurement of plasma amino acids by Ultraperformance® Liquid ChromatographyClinical Chemistry and Laboratory Medicine (CCLM), 2011
- LC–MS/MS progress in newborn screeningClinical Biochemistry, 2011
- Congenital disorders of glycosylationAnnals of the New York Academy of Sciences, 2010
- Recent advances in newborn screeningJournal of Inherited Metabolic Disease, 2007
- Inborn errors presenting with liver dysfunctionSeminars in Neonatology, 2002
- Incidence of Inborn Errors of Metabolism in British Columbia, 1969–1996Pediatrics, 2000
- Analysis of carbohydrate deficient transferrin by capillary zone electrophoresisElectrophoresis, 1997
- Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolismJournal of Inherited Metabolic Disease, 1990
- Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndromeClinica Chimica Acta, 1984
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977